09/10/2025
3:38 PM | MEI Pharma (Subject)
Schornstein Alexander (Filed by)
| Form SCHEDULE 13G/A | |
09/10/2025
3:40 PM | MEI Pharma (Issuer)
Schornstein Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/10/2025
8:00 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2025
11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
09/05/2025
3:36 PM | MEI Pharma (Filer)
| Form 424B3 | |
08/26/2025
4:21 PM | MEI Pharma (Filer)
| Form S-3/A | |
08/20/2025
4:56 PM | MEI Pharma (Issuer)
Riezman Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
4:54 PM | MEI Pharma (Issuer)
Riezman Joshua (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2025
4:32 PM | MEI Pharma (Subject)
Schornstein Alexander (Filed by)
| Form SCHEDULE 13G | |
08/05/2025
7:05 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
3:40 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MEIP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter. |
07/29/2025
4:23 PM | CITADEL ADVISORS LLC (Filed by)
MEI Pharma (Subject)
| Form SCHEDULE 13G | |
07/28/2025
6:20 PM | Anson Funds Management LP (Reporting)
MEI Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2025
6:18 PM | Funicular Funds, LP (Reporting)
MEI Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2025
4:22 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
8:33 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:36 PM | File Justin J. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:36 PM | Flynn James P (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:38 PM | Glover Nicholas (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:39 PM | MEI Pharma (Issuer)
Reynolds Thomas C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
8:40 PM | MEI Pharma (Issuer)
Wood Steven D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:30 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:10 PM | MEI Pharma (Filer)
| Form DEF 14A | |
12/20/2024
4:15 PM | MEI Pharma (Filer)
| Form DEFA14A | |
12/20/2024
4:20 PM | MEI Pharma (Filer)
| Form ARS | |
09/19/2024
4:20 PM | MEI Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/19/2024
4:05 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
